PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q4 2020. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $843,000 | -15.0% | 150,000 | -3.2% | 0.00% | -50.0% |
| Q3 2021 | $992,000 | -24.2% | 155,000 | -0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,308,000 | +4.8% | 155,065 | +30.3% | 0.00% | 0.0% |
| Q1 2021 | $1,248,000 | -47.4% | 119,000 | -15.0% | 0.00% | -60.0% |
| Q4 2020 | $2,372,000 | +49.1% | 140,000 | +12.9% | 0.01% | +66.7% |
| Q3 2020 | $1,591,000 | -1.1% | 124,000 | +8.8% | 0.00% | -25.0% |
| Q2 2020 | $1,609,000 | +108.2% | 114,000 | +35.7% | 0.00% | +100.0% |
| Q1 2020 | $773,000 | -0.3% | 84,000 | +61.5% | 0.00% | 0.0% |
| Q4 2019 | $775,000 | – | 52,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
| Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
| Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
| 683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
| Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
| GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
| Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
| Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
| Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |